GYNAECOLOGY CANCER RESEARCH FUND
Financial health, per its FY2022 accounts
The accounts state that the charity ended the year with a surplus and unrestricted reserves of £598,011, which is well above the agreed target operating reserves level of £180,000. The trustees report a cautious but stable financial position with an overall cash balance of £1,074,607, noting that the charity is well placed to manage operational and financial risks successfully.
What the accounts disclose
“The reserves policy was reviewed in 2022 and has been set by the Board as a target of holding £180,000 in free reserves. This target is based on the contingency for wind up funds, calculated to satisfy all the Charity’s liabilities in the event of closure. In real terms, £180,000 represents just under three months’ budgeted expenditure, excluding expenditure on research grants.” — page 28
“During the year under review, the Charity received income totalling £32,298 in donations from 15 Trustees, both current and resigned in the period, including partners (2021: £2,065 from 8 Trustees including partners). Reed Smith LLP provided pro bono legal services to the charity in the year totalling £70,138 (2021: £4,250). Tamara Box, a partner is Reed Smith LLP is also a Trustee of the charity.” — page 56
“The Charity had one 100% owned subsidiary company in the year. Eve Appeal Limited is a trading company that distributes its profits under Gift Aid to the Charity.” — page 24
Structured financials (annual return, FY ending 31/12/2024)
Register events
- Received assets from another charity (02/01/2018)
Trustees
- Tamara Boxchair
- Adam Rosenthal Prof.
- Christine Ekechi Dr
- Emma Dean
- Ian Jeffrey Jacobs
- Julia Levy
- Katharine Helen Byrne
- Marion O'Hara
- Sally Bailey
- Sarah Morris
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £1.8m | £1.7m |
| 31/12/2023 | £1.3m | £1.6m |
| 31/12/2022 | £1.6m | £1.7m |
| 31/12/2021 | £1.5m | £1.1m |
| 31/12/2020 | £1.8m | £1.8m |
Common questions
Is GYNAECOLOGY CANCER RESEARCH FUND financially healthy?
The accounts state that the charity ended the year with a surplus and unrestricted reserves of £598,011, which is well above the agreed target operating reserves level of £180,000. The trustees report a cautious but stable financial position with an overall cash balance of £1,074,607, noting that the charity is well placed to manage operational and financial risks successfully. Its FY2022 accounts were audited by Moore Kingston Smith LLP.
Who funds GYNAECOLOGY CANCER RESEARCH FUND?
Funders whose own accounts filings name GYNAECOLOGY CANCER RESEARCH FUND as a grant recipient include THE ORR MACKINTOSH FOUNDATION LIMITED, THE INMAN CHARITY, SCHRODER CHARITY TRUST, THE PETER STEBBINGS MEMORIAL CHARITY, THE HILARY AWDRY CHARITABLE TRUST.
Known funders
| Funder | Year | Amount |
|---|---|---|
| THE ORR MACKINTOSH FOUNDATION LIMITED | FY2025 | £10k |
| THE INMAN CHARITY | FY2023 | £7k |
| SCHRODER CHARITY TRUST | FY2024 | £5k |
| THE PETER STEBBINGS MEMORIAL CHARITY | FY2024 | £5k |
| THE HILARY AWDRY CHARITABLE TRUST | FY2023 | £1k |
Funders of similar charities
| Funder | Similar charities funded | Amount to them |
|---|---|---|
| DENISE COATES FOUNDATION | 1 | £411k |
| GARFIELD WESTON FOUNDATION | 1 | £250k |
| OPTIGENE FOUNDATION | 1 | £238k |
| THE TIM BACON FOUNDATION | 1 | £193k |
| THE 3 TS CHARITABLE TRUST | 1 | £160k |
| ASSOCIATION OF BREAST SURGERY | 1 | £95k |
| HOLLYHOCK CHARITABLE FOUNDATION | 1 | £53k |
| THE SCHRODER FOUNDATION | 1 | £50k |